1 | eradication | 3,226 |
2 | positivity | 1,097 |
3 | seroconversion | 902 |
4 | expulsion | 728 |
5 | seropositivity | 299 |
6 | negativity | 277 |
7 | cancellation | 165 |
8 | subsidence | 98 |
9 | sero-conversion | 20 |
10 | immunolabelling | 16 |
11 | sanguinea | 13 |
12 | photoinactivation | 11 |
13 | limb-salvage | 9 |
14 | cancelation | 8 |
15 | seroprotection/seropositivity | 8 |
16 | autostrains | 7 |
17 | dhq25 | 6 |
18 | first-incidence | 6 |
19 | oric | 6 |
20 | micronuclear | 5 |
21 | punctuation | 5 |
22 | re-amputation | 5 |
23 | sero-response | 5 |
24 | 27-hydroxylation | 4 |
25 | igg-positive | 4 |
26 | bugensis | 3 |
27 | dani | 3 |
28 | eradiation | 3 |
29 | post-larvae | 3 |
30 | recurrence/persistence | 3 |
31 | sero-positivity | 3 |
32 | undertriage | 3 |
33 | ad27 | 2 |
34 | apoai/apob | 2 |
35 | cass. | 2 |
36 | ggt-mediated | 2 |
37 | h93616 | 2 |
38 | in-calf | 2 |
39 | levofloxacin/amoxicillin | 2 |
40 | resistency | 2 |
41 | screen-detection | 2 |
42 | takagi | 2 |
43 | .levothyroxine | 1 |
44 | .miscarriage | 1 |
45 | /fracture | 1 |
46 | /gls | 1 |
47 | /δwork | 1 |
48 | 3,4-methylenedioxymetamphetamine | 1 |
49 | 31.2×mic | 1 |
50 | 60190 | 1 |
51 | amennorhea | 1 |
52 | apothecia | 1 |
53 | clearance/seroconversion | 1 |
54 | comparable-to-or-higher | 1 |
55 | decline/progression | 1 |
56 | drury | 1 |
57 | imics | 1 |
58 | jaub | 1 |
59 | kånneby | 1 |
60 | lfs10 | 1 |
61 | luxuriantly | 1 |
62 | lászló | 1 |
63 | manden. | 1 |
64 | n-butyl-n-4hydroxybutylnitrosamine | 1 |
65 | nat-yield | 1 |
66 | od/co | 1 |
67 | pellegr | 1 |
68 | sarl4b | 1 |
69 | screening-eradication | 1 |
70 | seropositivity/infection | 1 |
71 | supertexta | 1 |
72 | target-attainment | 1 |
1 | .levothyroxine | 1 |
2 | .miscarriage | 1 |
3 | /fracture | 1 |
4 | /gls | 1 |
5 | /δwork | 1 |
6 | 27-hydroxylation | 4 |
7 | 3,4-methylenedioxymetamphetamine | 1 |
8 | 31.2×mic | 1 |
9 | 60190 | 1 |
10 | ad27 | 2 |
11 | amennorhea | 1 |
12 | apoai/apob | 2 |
13 | apothecia | 1 |
14 | autostrains | 7 |
15 | bugensis | 3 |
16 | cancelation | 8 |
17 | cancellation | 165 |
18 | cass. | 2 |
19 | clearance/seroconversion | 1 |
20 | comparable-to-or-higher | 1 |
21 | dani | 3 |
22 | decline/progression | 1 |
23 | dhq25 | 6 |
24 | drury | 1 |
25 | eradiation | 3 |
26 | eradication | 3,226 |
27 | expulsion | 728 |
28 | first-incidence | 6 |
29 | ggt-mediated | 2 |
30 | h93616 | 2 |
31 | igg-positive | 4 |
32 | imics | 1 |
33 | immunolabelling | 16 |
34 | in-calf | 2 |
35 | jaub | 1 |
36 | kånneby | 1 |
37 | levofloxacin/amoxicillin | 2 |
38 | lfs10 | 1 |
39 | limb-salvage | 9 |
40 | luxuriantly | 1 |
41 | lászló | 1 |
42 | manden. | 1 |
43 | micronuclear | 5 |
44 | n-butyl-n-4hydroxybutylnitrosamine | 1 |
45 | nat-yield | 1 |
46 | negativity | 277 |
47 | od/co | 1 |
48 | oric | 6 |
49 | pellegr | 1 |
50 | photoinactivation | 11 |
51 | positivity | 1,097 |
52 | post-larvae | 3 |
53 | punctuation | 5 |
54 | re-amputation | 5 |
55 | recurrence/persistence | 3 |
56 | resistency | 2 |
57 | sanguinea | 13 |
58 | sarl4b | 1 |
59 | screen-detection | 2 |
60 | screening-eradication | 1 |
61 | sero-conversion | 20 |
62 | sero-positivity | 3 |
63 | sero-response | 5 |
64 | seroconversion | 902 |
65 | seropositivity | 299 |
66 | seropositivity/infection | 1 |
67 | seroprotection/seropositivity | 8 |
68 | subsidence | 98 |
69 | supertexta | 1 |
70 | takagi | 2 |
71 | target-attainment | 1 |
72 | undertriage | 3 |
1 | manden. | 1 |
2 | cass. | 2 |
3 | lfs10 | 1 |
4 | 60190 | 1 |
5 | dhq25 | 6 |
6 | h93616 | 2 |
7 | ad27 | 2 |
8 | amennorhea | 1 |
9 | sanguinea | 13 |
10 | apothecia | 1 |
11 | supertexta | 1 |
12 | sarl4b | 1 |
13 | apoai/apob | 2 |
14 | jaub | 1 |
15 | 31.2×mic | 1 |
16 | oric | 6 |
17 | ggt-mediated | 2 |
18 | nat-yield | 1 |
19 | post-larvae | 3 |
20 | first-incidence | 6 |
21 | subsidence | 98 |
22 | recurrence/persistence | 3 |
23 | .miscarriage | 1 |
24 | undertriage | 3 |
25 | limb-salvage | 9 |
26 | n-butyl-n-4hydroxybutylnitrosamine | 1 |
27 | 3,4-methylenedioxymetamphetamine | 1 |
28 | .levothyroxine | 1 |
29 | /fracture | 1 |
30 | sero-response | 5 |
31 | igg-positive | 4 |
32 | in-calf | 2 |
33 | immunolabelling | 16 |
34 | takagi | 2 |
35 | dani | 3 |
36 | /δwork | 1 |
37 | levofloxacin/amoxicillin | 2 |
38 | expulsion | 728 |
39 | sero-conversion | 20 |
40 | seroconversion | 902 |
41 | clearance/seroconversion | 1 |
42 | decline/progression | 1 |
43 | eradication | 3,226 |
44 | screening-eradication | 1 |
45 | eradiation | 3 |
46 | cancelation | 8 |
47 | cancellation | 165 |
48 | 27-hydroxylation | 4 |
49 | re-amputation | 5 |
50 | punctuation | 5 |
51 | photoinactivation | 11 |
52 | seropositivity/infection | 1 |
53 | screen-detection | 2 |
54 | od/co | 1 |
55 | micronuclear | 5 |
56 | comparable-to-or-higher | 1 |
57 | pellegr | 1 |
58 | imics | 1 |
59 | bugensis | 3 |
60 | /gls | 1 |
61 | autostrains | 7 |
62 | target-attainment | 1 |
63 | kånneby | 1 |
64 | resistency | 2 |
65 | luxuriantly | 1 |
66 | drury | 1 |
67 | negativity | 277 |
68 | positivity | 1,097 |
69 | sero-positivity | 3 |
70 | seropositivity | 299 |
71 | seroprotection/seropositivity | 8 |
72 | lászló | 1 |